comprehensive -WSS

comprehensive

author：knowledge 2025-09-06 03:40:12 - browse：5972

Pascal Soriot - Senate Finance Committee — AstraZeneca CEO Pascal Soriot Jacquelyn Martin/AP

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals. On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.

“We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Robert Kennedy Jr.'s presidential campaign attracts GOP

focus

WSS

Pancreatic cancer is often deadly, but new discoveries are raising hope

Manchin plays down potential 3rd

Why you get paid to donate plasma but not blood

Manchin plays down potential 3rd

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

hotspot

comprehensive

hotspot

Jerome Adams on the need for new antivirals for Covid

Hundreds died while taking an arthritis drug, but nobody alerted patients

Cancer drug shortages should be causing more outrage

Four alarming medical procedures we’re glad history forgot

Apple is now the first public company to be valued at $3 trillion

Insurer loopholes limit power of law against surprise medical bills

Supreme Court strikes down use of affirmative action

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Alkermes shareholders re

Four alarming medical procedures we’re glad history forgot

focus

Oral obesity drug from Viking Therapeutics hits key early target

Four alarming medical procedures we’re glad history forgot

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Robert Kennedy Jr.'s presidential campaign attracts GOP

Insurer loopholes limit power of law against surprise medical bills

15 die by electrocution after transformer explodes in northern India

explore

focus

focus

entertainment